
IndraLab
Statements
sparser
"Another recent mouse study presented protective and anti-inflammatory effects of MKEY (a specific peptide blocking the CCL5-CXCR4 interaction) in a myocardial ischemia/reperfusion injury model and suggested that it could be used therapeutically in atherosclerosis and myocardial infarction treatment [ xref ]."
sparser
"Furthermore, administration of a CCL2 competitor reduced monocyte recruitment, which attenuated MI-R injury ( xref ), and pharmacological blockage of the CCL5-CXCR4 interaction impaired the inflammatory response resulting in a reduced infarct size and preserved cardiac function ( xref )."